Report cover image

Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Aug 17, 2024
Length 133 Pages
SKU # PROD19315632

Description

Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global dementia drugs market is expected to grow at a CAGR of around 7.9% during 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia drugs market by segmenting the market based on drug class, indication, distribution channel, and region. Also, detailed profiles of companies operating in the dementia drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Prevalence of Target Diseases
• Introduction of New and Innovative Technologies and Drugs

Market Challenges

• High Failure Rates of Drugs at Approval Stages
• High Costs Associated with Research and Development Activities

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Drug Class

• Cholinesterase Inhibitors
• NMDA Antagonists and its Combination Drugs

Market by Indication

• Lewy Body Dementia
• Parkinsons Disease Dementia
• Alzheimers Disease
• Vascular Dementia
• Others

Market by Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
 

Table of Contents

133 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Dementia Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Dementia Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Dementia Drugs Market by Drug Class
5.1. Introduction
5.2. Cholinesterase Inhibitors
5.3. NMDA Antagonists and its Combination Drugs
6. Global Dementia Drugs Market by Indication
6.1. Introduction
6.2. Lewy Body Dementia
6.3. Parkinsons Disease Dementia
6.4. Alzheimers Disease
6.5. Vascular Dementia
6.6. Others
7. Global Dementia Drugs Market by Distribution Channel
7.1. Introduction
7.2. Retail Pharmacies
7.3. Hospital Pharmacies
7.4. Online Pharmacies
8. Global Dementia Drugs Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Annovis Bio
12.2.2. AstraZeneca
12.2.3. Athira Pharma
12.2.4. Aurobindo Pharma
12.2.5. Biogen
12.2.6. Eisai Co. Ltd
12.2.7. Eli Lilly and Company
12.2.8. GlaxoSmithKline PLC
12.2.9. Johnson and Johnson
12.2.10. Merck & Co. Inc.
12.2.11. Pfizer Inc.
12.2.12. SK Capital (Apotex Pharmaceutical Holdings Inc.)
12.2.13. Teva Pharmaceuticals
12.2.14. Zydus Cadila
List of Figures
Figure 1: Global Dementia Drugs Market (in US$ Million), 2020-2024
Figure 2: Global Dementia Drugs Market by Drug Class, 2024
Figure 3: Global Dementia Drugs Market by Indication, 2024
Figure 4: Global Dementia Drugs Market by Distribution Channel, 2024
Figure 5: Global Dementia Drugs Market by Region, 2024
Figure 6: Global Dementia Drugs Market (in US$ Million), 2025-2034
Figure 7: Global Dementia Drugs Market by Drug Class (in %), 2024 & 2034
Figure 8: Global Cholinesterase Inhibitors Dementia Drugs Market (in US$ Million), 2020-2024
Figure 9: Global Cholinesterase Inhibitors Dementia Drugs Market (in US$ Million), 2025-2034
Figure 10: Global NMDA Antagonists and its Combination Drugs Dementia Drugs Market (in US$ Million), 2020-2024
Figure 11: Global NMDA Antagonists and its Combination Drugs Dementia Drugs Market (in US$ Million), 2025-2034
Figure 12: Global Dementia Drugs Market by Indication (in %), 2024 & 2034
Figure 13: Global Lewy Body Dementia Drugs Market (in US$ Million), 2020-2024
Figure 14: Global Lewy Body Dementia Drugs Market (in US$ Million), 2025-2034
Figure 15: Global Parkinsons Disease Dementia Drugs Market (in US$ Million), 2020-2024
Figure 16: Global Parkinsons Disease Dementia Drugs Market (in US$ Million), 2025-2034
Figure 17: Global Alzheimers Disease Dementia Drugs Market (in US$ Million), 2020-2024
Figure 18: Global Alzheimers Disease Dementia Drugs Market (in US$ Million), 2025-2034
Figure 19: Global Vascular Dementia Drugs Market (in US$ Million), 2020-2024
Figure 20: Global Vascular Dementia Drugs Market (in US$ Million), 2025-2034
Figure 21: Global Other Indications Dementia Drugs Market (in US$ Million), 2020-2024
Figure 22: Global Other Indications Dementia Drugs Market (in US$ Million), 2025-2034
Figure 23: Global Dementia Drugs Market by Distribution Channel (in %), 2024 & 2034
Figure 24: Global Retail Pharmacies Dementia Drugs Market (in US$ Million), 2020-2024
Figure 25: Global Retail Pharmacies Dementia Drugs Market (in US$ Million), 2025-2034
Figure 26: Global Hospital Pharmacies Dementia Drugs Market (in US$ Million), 2020-2024
Figure 27: Global Hospital Pharmacies Dementia Drugs Market (in US$ Million), 2025-2034
Figure 28: Global Online Pharmacies Dementia Drugs Market (in US$ Million), 2020-2024
Figure 29: Global Online Pharmacies Dementia Drugs Market (in US$ Million), 2025-2034
Figure 30: Global Dementia Drugs Market by Region (in %), 2024 & 2034
Figure 31: Europe Dementia Drugs Market (in US$ Million), 2020-2024
Figure 32: Europe Dementia Drugs Market (in US$ Million), 2025-2034
Figure 33: Europe Dementia Drugs Market by Country (in %), 2024 & 2034
Figure 34: Germany Dementia Drugs Market (in US$ Million), 2020-2034
Figure 35: United Kingdom Dementia Drugs Market (in US$ Million), 2020-2034
Figure 36: France Dementia Drugs Market (in US$ Million), 2020-2034
Figure 37: Italy Dementia Drugs Market (in US$ Million), 2020-2034
Figure 38: Spain Dementia Drugs Market (in US$ Million), 2020-2034
Figure 39: Russia Dementia Drugs Market (in US$ Million), 2020-2034
Figure 40: Netherlands Dementia Drugs Market (in US$ Million), 2020-2034
Figure 41: North America Dementia Drugs Market (in US$ Million), 2020-2024
Figure 42: North America Dementia Drugs Market (in US$ Million), 2025-2034
Figure 43: North America Dementia Drugs Market by Country (in %), 2024 & 2034
Figure 44: United States Dementia Drugs Market (in US$ Million), 2020-2034
Figure 45: Canada Dementia Drugs Market (in US$ Million), 2020-2034
Figure 46: Asia Pacific Dementia Drugs Market (in US$ Million), 2020-2024
Figure 47: Asia Pacific Dementia Drugs Market (in US$ Million), 2025-2034
Figure 48: Asia Pacific Dementia Drugs Market by Country (in %), 2024 & 2034
Figure 49: China Dementia Drugs Market (in US$ Million), 2020-2034
Figure 50: Japan Dementia Drugs Market (in US$ Million), 2020-2034
Figure 51: India Dementia Drugs Market (in US$ Million), 2020-2034
Figure 52: South Korea Dementia Drugs Market (in US$ Million), 2020-2034
Figure 53: Australia Dementia Drugs Market (in US$ Million), 2020-2034
Figure 54: Indonesia Dementia Drugs Market (in US$ Million), 2020-2034
Figure 55: Latin America Dementia Drugs Market (in US$ Million), 2020-2024
Figure 56: Latin America Dementia Drugs Market (in US$ Million), 2025-2034
Figure 57: Latin America Dementia Drugs Market by Country (in %), 2024 & 2034
Figure 58: Mexico Dementia Drugs Market (in US$ Million), 2020-2034
Figure 59: Brazil Dementia Drugs Market (in US$ Million), 2020-2034
Figure 60: Argentina Dementia Drugs Market (in US$ Million), 2020-2034
Figure 61: Middle East & Africa Dementia Drugs Market (in US$ Million), 2020-2024
Figure 62: Middle East & Africa Dementia Drugs Market (in US$ Million), 2025-2034
Figure 63: Middle East & Africa Dementia Drugs Market by Country (in %), 2024 & 2034
Figure 64: Saudi Arabia Dementia Drugs Market (in US$ Million), 2020-2034
Figure 65: Turkey Dementia Drugs Market (in US$ Million), 2020-2034
Figure 66: Iran Dementia Drugs Market (in US$ Million), 2020-2034
Figure 67: UAE Dementia Drugs Market (in US$ Million), 2020-2034
Figure 68: Market Value Chain
List of Tables
Table 1: Global Dementia Drugs Market Portraiture
Table 2: Global Dementia Drugs Market by Drug Class (in US$ Million), 2024 & 2034
Table 3: Global Dementia Drugs Market by Indication (in US$ Million), 2024 & 2034
Table 4: Global Dementia Drugs Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 5: Global Dementia Drugs Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Dementia Drugs Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Dementia Drugs Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Dementia Drugs Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Dementia Drugs Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Dementia Drugs Market by Country (in US$ Million),
2024 & 2034
Table 11: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us